JP5770965B2 - オリゴペプチドおよびその使用 - Google Patents

オリゴペプチドおよびその使用 Download PDF

Info

Publication number
JP5770965B2
JP5770965B2 JP2008539289A JP2008539289A JP5770965B2 JP 5770965 B2 JP5770965 B2 JP 5770965B2 JP 2008539289 A JP2008539289 A JP 2008539289A JP 2008539289 A JP2008539289 A JP 2008539289A JP 5770965 B2 JP5770965 B2 JP 5770965B2
Authority
JP
Japan
Prior art keywords
acid
oil
group
phe
tyr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008539289A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009514906A (ja
JP2009514906A5 (https=
Inventor
ベロニク・ジロン
フィリップ・ムソー
ジャン−リュク・コンテ−オドノー
オルガ・フレ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cognis IP Management GmbH
Original Assignee
Cognis IP Management GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognis IP Management GmbH filed Critical Cognis IP Management GmbH
Publication of JP2009514906A publication Critical patent/JP2009514906A/ja
Publication of JP2009514906A5 publication Critical patent/JP2009514906A5/ja
Application granted granted Critical
Publication of JP5770965B2 publication Critical patent/JP5770965B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
JP2008539289A 2005-11-03 2006-10-25 オリゴペプチドおよびその使用 Expired - Fee Related JP5770965B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05023954A EP1782819A1 (en) 2005-11-03 2005-11-03 Oligopeptides and their use
EP05023954.0 2005-11-03
PCT/EP2006/010258 WO2007051550A1 (en) 2005-11-03 2006-10-25 Oligopeptides and their use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013149195A Division JP5837539B2 (ja) 2005-11-03 2013-07-18 オリゴペプチドおよびその使用

Publications (3)

Publication Number Publication Date
JP2009514906A JP2009514906A (ja) 2009-04-09
JP2009514906A5 JP2009514906A5 (https=) 2010-12-16
JP5770965B2 true JP5770965B2 (ja) 2015-08-26

Family

ID=36371046

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008539289A Expired - Fee Related JP5770965B2 (ja) 2005-11-03 2006-10-25 オリゴペプチドおよびその使用
JP2013149195A Expired - Fee Related JP5837539B2 (ja) 2005-11-03 2013-07-18 オリゴペプチドおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013149195A Expired - Fee Related JP5837539B2 (ja) 2005-11-03 2013-07-18 オリゴペプチドおよびその使用

Country Status (7)

Country Link
US (2) US8101574B2 (https=)
EP (2) EP1782819A1 (https=)
JP (2) JP5770965B2 (https=)
KR (1) KR101421742B1 (https=)
DE (1) DE602006009296D1 (https=)
ES (1) ES2332740T3 (https=)
WO (1) WO2007051550A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1782819A1 (en) * 2005-11-03 2007-05-09 Cognis IP Management GmbH Oligopeptides and their use
DE102009002285A1 (de) * 2009-04-08 2010-10-14 Henkel Ag & Co. Kgaa Kopfhautschonende Shampoos und Conditioner
IT1407715B1 (it) * 2010-06-18 2014-04-30 Alphrema Srl Composizioni ad uso topico per la profilassi ed il trattamento igienico di alcune problematiche di patologia ano-rettale, come emorroidi, ragadi, ascessi e fistole.
US9511144B2 (en) 2013-03-14 2016-12-06 The Proctor & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
FR3012811B1 (fr) * 2013-11-05 2015-12-25 Basf Beauty Care Solutions France Sas Oligopeptides et leurs utilisations
ITBS20130177A1 (it) * 2013-11-27 2015-05-28 Gianpaolo Pizzoli Preparazione cosmetica
US20170281509A1 (en) * 2014-09-12 2017-10-05 Gojo Industries, Inc. Compositions and methods for mitigating skin irritation
KR101851236B1 (ko) 2015-07-06 2018-04-24 김철군 동충하초 재배용 배지조성물 및 동충하초 재배방법
US20190248834A1 (en) * 2016-06-27 2019-08-15 Ruey J. Yu Endomorphin-2, tetrapeptide derivatives thereof, and uses thereof
KR20190065916A (ko) 2017-12-04 2019-06-12 김철군 동충하초 재배용 배지조성물 및 동충하초의 재배방법
CN119143848B (zh) * 2023-12-26 2025-11-25 杭州湃肽生化科技有限公司 环七肽-4及其制备方法及应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU68901A1 (https=) 1973-11-30 1975-08-20
US4172887A (en) * 1973-11-30 1979-10-30 L'oreal Hair conditioning compositions containing crosslinked polyaminopolyamides
NL8005121A (nl) 1979-09-20 1981-03-24 Erba Farmitalia Biologisch actieve peptiden.
JPS6299315A (ja) * 1985-10-25 1987-05-08 Kanebo Ltd 皮膚化粧料
US5702688A (en) * 1986-12-23 1997-12-30 Tristrata Technology, Inc. Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
US4966848A (en) * 1988-02-08 1990-10-30 The General Hospital Corporation Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
SE9503924D0 (sv) 1995-08-18 1995-11-07 Astra Ab Novel opioid peptides
IS4261A (is) 1994-02-21 1995-08-22 Astra Aktiebolag Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra
JPH0848695A (ja) * 1994-08-05 1996-02-20 Meito Sangyo Kk ポルフイロモナス・ジンジバリスのタイプｉｉ線毛蛋白質の配列を含有するペプチド類及びその用途
JPH08337537A (ja) * 1995-06-15 1996-12-24 Kao Corp 細胞間接着阻害ペプチド
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
US5763576A (en) * 1995-10-06 1998-06-09 Georgia Tech Research Corp. Tetrapeptide α-ketoamides
US5885958A (en) 1997-03-25 1999-03-23 Administrators Of The Tulane Educational Fund Mu-opiate receptor peptides
JPH10330398A (ja) * 1997-05-28 1998-12-15 Asahi Glass Co Ltd 新規環状ペプチド
DE19756377A1 (de) 1997-12-18 1999-06-24 Beiersdorf Ag Verwendung von C¶1¶¶8¶-¶3¶¶8¶-Alkylhydroxystearoylstearat zur Verstärkung der UV-A-Schutzleistung kosmetischer oder dermatologischer Formulierungen
PL189753B1 (pl) * 1998-11-12 2005-09-30 Victor Hruby Nowe pochodne peptydowe o aktywności przeciwbólowej oraz sposób ich otrzymywania
US6048902A (en) * 1999-02-12 2000-04-11 Lebwohl; Mark G. Short contact treatment of psoriasis with topical retinoids
IL153359A0 (en) * 2000-06-16 2003-07-06 Hercules Inc Peptides, compositions and methods for the treatment of burkholderia cepacia
WO2002010195A2 (en) * 2000-08-02 2002-02-07 Theratechnologies Inc. Modified peptides with increased potency
US7148197B2 (en) * 2000-08-24 2006-12-12 The Regents Of The University Of California Orally administered small peptides synergize statin activity
DE10106852A1 (de) * 2001-02-14 2002-09-05 T Luger Entzündungshemmende Verbindungen
EP1427438A2 (en) 2001-09-03 2004-06-16 The University of Bristol Inflammation modulatory compound comprising an endomorphin
JP2004175687A (ja) 2002-11-25 2004-06-24 Shiseido Co Ltd 皮膚バリアー機能回復促進剤
FR2857588B1 (fr) * 2003-07-17 2007-11-30 Oreal Utilisation de beta-endorphine, d'agents exercant une activite beta-endorphine-like en cosmetique et dermatologie
EP1982997B1 (en) * 2004-09-01 2012-08-08 Allergan, Inc. Degradable clostridial toxins
EP1782819A1 (en) * 2005-11-03 2007-05-09 Cognis IP Management GmbH Oligopeptides and their use
WO2008056207A1 (en) * 2006-11-08 2008-05-15 Chongxi Yu Transdermal delivery systems of peptides and related compounds
DE102009002286A1 (de) * 2009-04-08 2010-02-11 Henkel Ag & Co. Kgaa Haarfärbe/wellmittel mit verbesserter Hautverträglichkeit
EP2427475B1 (en) * 2009-05-08 2020-11-04 Techfields Biochem Co., Ltd. High penetration prodrug compositions of peptides and peptide-related compounds
WO2011146922A2 (en) * 2010-05-21 2011-11-24 Cytogel Pharma, Llc Materials and methods for treatment of inflammation

Also Published As

Publication number Publication date
US20120129784A1 (en) 2012-05-24
KR101421742B1 (ko) 2014-07-30
JP5837539B2 (ja) 2015-12-24
US8101574B2 (en) 2012-01-24
US8399415B2 (en) 2013-03-19
JP2009514906A (ja) 2009-04-09
JP2013241433A (ja) 2013-12-05
ES2332740T3 (es) 2010-02-11
EP1782819A1 (en) 2007-05-09
EP1951276B1 (en) 2009-09-16
WO2007051550A1 (en) 2007-05-10
DE602006009296D1 (de) 2009-10-29
EP1951276A1 (en) 2008-08-06
US20090075906A1 (en) 2009-03-19
KR20080067343A (ko) 2008-07-18

Similar Documents

Publication Publication Date Title
JP5837539B2 (ja) オリゴペプチドおよびその使用
JP2004529866A (ja) 化粧用および／または医薬用製剤
JP5858985B2 (ja) オリゴペプチド含有化粧品組成物
JP2005516019A (ja) エモリエント剤及び化粧品製剤
JP2012101224A (ja) 自己乳化性組成物
JP2003525877A (ja) 防臭製剤
JP2004501176A (ja) イヌリンおよびイヌリン誘導体の使用
JP2005526782A (ja) 化粧用製剤用の油相
JP2004514688A (ja) 化粧品用および／または薬剤用エマルジョン
JP2009535369A (ja) 増粘剤
JP2003530419A (ja) 化粧品製剤の製造における天然物質の使用
JP5324781B2 (ja) Ｐｔｈ断片含有化粧品
JP2004532279A (ja) 界面活性剤混合物
JP2004512290A (ja) 可溶化剤としての脂肪アルコールの使用
JP2003531832A (ja) プロリポソーム封入製剤（ｉｖ）
FR3076722A1 (fr) Association synergique de tétrapeptides
JP2007112798A (ja) 乳白剤
JP2003521505A (ja) Ｗａｌｔｈｅｒｉａｉｎｄｉｃａ抽出物を含有する化粧品製剤
JP2005529177A (ja) 共役リノール酸のアルコールを含む製剤
JP2006514074A (ja) 化粧品または皮膚科学的調製物におけるオリゴグルコサミンの使用
JP2003528894A (ja) プロリポソーム封入調製物
JP2004527550A (ja) カチオン性製剤の使用
JP2005513121A (ja) エモリエント剤及び化粧品製剤
JP2003535881A (ja) ヒトの皮膚を保護する方法
JP2003502352A (ja) ゲルベアルコール

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091023

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091023

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120327

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120625

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130319

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130718

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20130725

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20130906

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150227

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150401

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150427

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150427

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150626

R150 Certificate of patent or registration of utility model

Ref document number: 5770965

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees